SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Fang Wei, Shu Xu, Xiaoyi Jia, Xiaojing Sun, Xuezhi Yang, Wei Wei, Yan Chang, BAFF and its receptors involved in the inflammation progress in adjuvant induced arthritis rats, International Immunopharmacology, 2016, 31, 1

    CrossRef

  2. 2
    G.I. Godahewa, N.C.N. Perera, Navaneethaiyer Umasuthan, Qiang Wan, Ilson Whang, Jehee Lee, Molecular characterization and expression analysis of B cell activating factor from rock bream (Oplegnathus fasciatus), Developmental & Comparative Immunology, 2016, 55, 1

    CrossRef

  3. 3
    Yan Chang, Xiaoyi Jia, Xiaojing Sun, Shu Xu, Yujing Wu, Lingling Zhang, Wei Wei, APRIL promotes proliferation, secretion and invasion of fibroblast-like synoviocyte from rats with adjuvant induced arthritis, Molecular Immunology, 2015, 64, 1, 90

    CrossRef

  4. 4
    Yan Chang, Xiaojing Sun, Xiaoyi Jia, Shu Xu, Fang Wei, Xuezhi Yang, Wei Wei, Expression and effects of B-lymphocyte stimulator and its receptors in T cell-mediated autoimmune arthritis, International Immunopharmacology, 2015, 24, 2, 451

    CrossRef

  5. 5
    R. F. van Vollenhoven, S. Wax, Y. Li, P. P. Tak, Safety and Efficacy of Atacicept in Combination With Rituximab for Reducing the Signs and Symptoms of Rheumatoid Arthritis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Pilot Trial, Arthritis & Rheumatology, 2015, 67, 11
  6. 6
    Fang Wei, Yan Chang, Wei Wei, The role of BAFF in the progression of rheumatoid arthritis, Cytokine, 2015, 76, 2, 537

    CrossRef

  7. 7
    Thomas Dörner, Peter E. Lipsky, B cells, Current Opinion in Rheumatology, 2014, 26, 2, 228

    CrossRef

  8. 8
    Eliana Mariño, Stacey N. Walters, Jeanette E. Villanueva, James L. Richards, Charles R. Mackay, Shane T. Grey, BAFF regulates activation of self-reactive T cells through B-cell dependent mechanisms and mediates protection in NOD mice, European Journal of Immunology, 2014, 44, 4
  9. 9
    Gary Reynolds, Faye AH Cooles, John D Isaacs, Catharien MU Hilkens, Emerging immunotherapies for rheumatoid arthritis, Human Vaccines & Immunotherapeutics, 2014, 10, 4, 822

    CrossRef

  10. 10
    Ghada Boghdadi, Enass A. Elewa, Increased serum APRIL differentially correlates with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients, Rheumatology International, 2014, 34, 9, 1217

    CrossRef

  11. 11
    J Zhao, J Guo, L Wang, W Zhou, Z Zhang, The role of a proliferation-inducing ligand (APRIL) in the pathogenesis of rheumatoid arthritis, Scandinavian Journal of Rheumatology, 2014, 43, 6, 462

    CrossRef

  12. 12
    Guo-dong Feng, Xiao-chang Xue, Mei-li Gao, Xian-feng Wang, Zhen Shu, Nan Mu, Yuan Gao, Zeng-lu Wang, Qiang Hao, Wei-na Li, Meng Li, Cun Zhang, Wei Zhang, Ying-qi Zhang, Therapeutic Effects of PADRE-BAFF Autovaccine on Rat Adjuvant Arthritis, BioMed Research International, 2014, 2014, 1

    CrossRef

  13. 13
    Geun-Hee Lee, Jiyoung Lee, Jae-Wook Lee, Whan Soo Choi, Eun-Yi Moon, B cell activating factor-dependent expression of vascular endothelial growth factor in MH7A human synoviocytes stimulated with tumor necrosis factor-α, International Immunopharmacology, 2013, 17, 1, 142

    CrossRef

  14. 14
    Gaurav Malviya, Simonetta Salemi, Bruno Laganà, Andrea Picchianti Diamanti, Raffaele D’Amelio, Alberto Signore, Biological Therapies for Rheumatoid Arthritis: Progress to Date, BioDrugs, 2013, 27, 4, 329

    CrossRef

  15. 15
    I. Debnath, K. M. Roundy, P. D. Pioli, J. J. Weis, J. H. Weis, Bone marrow-induced Mef2c deficiency delays B-cell development and alters the expression of key B-cell regulatory proteins, International Immunology, 2013, 25, 2, 99

    CrossRef

  16. 16
    Xin-guang Liu, Ming Hou, Immune Thrombocytopenia and B-Cell-Activating Factor/A Proliferation-Inducing Ligand, Seminars in Hematology, 2013, 50, S89

    CrossRef

  17. 17
    Xia Liu, Xue-mei Ji, Xi-ning Du, Xi-cui Zong, Ding-fang Liang, Li Ma, Hai-tao Wu, Shuang-quan Zhang, Molecular Cloning, Expression, Bioinformatics Analysis, and Bioactivity of TNFSF13 (APRIL) in the South African Clawed Frog (Xenopus laevi): A New Model to Study Immunological Diseases, OMICS: A Journal of Integrative Biology, 2013, 17, 7, 384

    CrossRef

  18. 18
    S. Modi, M. Soejima, M. C. Levesque, The effect of targeted rheumatoid arthritis therapies on anti-citrullinated protein autoantibody levels and B cell responses, Clinical & Experimental Immunology, 2013, 173, 1
  19. 19
    L. Fernandez, G. F. Salinas, C. Rocha, C. E. Carvalho-Pinto, N. Yeremenko, L. Papon, J. P. Medema, B. Combe, J. Morel, D. Baeten, M. Hahne, The TNF family member APRIL dampens collagen-induced arthritis, Annals of the Rheumatic Diseases, 2013, 72, 8, 1367

    CrossRef

  20. 20
    Martina Fabris, Luca Quartuccio, Ed Vital, Elena Pontarini, Sara Salvin, Cinzia Fabro, Alen Zabotti, Maurizio Benucci, Mariangela Manfredi, Viviana Ravagnani, Domenico Biasi, Fabiola Atzeni, Piercarlo Sarzi-Puttini, Pia Morassi, Fabio Fischetti, Laura Bazzicchi, Marta Saracco, Raffaele Pellerito, Marco Cimmino, Valeria Carraro, Angelo Semeraro, Franco Schiavon, Roberto Caporali, Roberto Bortolotti, Marcello Govoni, Federico Fogolari, Elio Tonutti, Stefano Bombardieri, Paul Emery, Salvatore De Vita, The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers, Arthritis & Rheumatism, 2013, 65, 1
  21. 21
    Manuela Zonca, Pablo Mancheño-Corvo, Olga DelaRosa, Santos Mañes, Dirk Büscher, Eleuterio Lombardo, Lourdes Planelles, APRIL and BAFF Proteins Increase Proliferation of Human Adipose-Derived Stem Cells Through Activation of Erk1/2 MAP Kinase, Tissue Engineering Part A, 2012, 18, 7-8, 852

    CrossRef

  22. 22
    Yan Geng, Zhuo-li Zhang, Comparative study on the level of B lymphocyte stimulator (BlyS) and frequency of lymphocytes between sero-negative and sero-positive rheumatoid arthritis patients, International Journal of Rheumatic Diseases, 2012, 15, 5
  23. 23
    Takumi Furuya, Minori Koga, Koki Hikami, Aya Kawasaki, Naoyuki Tsuchiya, Effects ofAPRIL(TNFSF13) polymorphisms and splicing isoforms on the secretion of soluble APRIL, Modern Rheumatology, 2012, 22, 4, 541

    CrossRef

  24. 24
    Takumi Furuya, Minori Koga, Koki Hikami, Aya Kawasaki, Naoyuki Tsuchiya, Effects ofAPRIL(TNFSF13) polymorphisms and splicing isoforms on the secretion of soluble APRIL, Modern Rheumatology, 2012, 22, 4, 541

    CrossRef

  25. 25
    Xian-wei Cui, Wen Xiao, Chen-bo Ji, Ai-ying Tian, Jie Zhang, Shuang-quan Zhang, Gene cloning, expression and functional characterization of a proliferation-inducing ligand (APRIL) from hedgehog (Erinaceus europaeus), Molecular Biology Reports, 2012, 39, 5, 6123

    CrossRef

  26. 26
    Rita A. Moura, Luis Graca, João E. Fonseca, To B or Not to B the Conductor of Rheumatoid Arthritis Orchestra, Clinical Reviews in Allergy & Immunology, 2012, 43, 3, 281

    CrossRef

  27. 27
    R. F. van Vollenhoven, N. Kinnman, E. Vincent, S. Wax, J. Bathon, Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a phase II, randomized, placebo-controlled trial, Arthritis & Rheumatism, 2011, 63, 7
  28. 28
    M. C. Genovese, N. Kinnman, G. de La Bourdonnaye, C. Pena Rossi, P. P. Tak, Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: Results of a phase II, randomized, placebo-controlled, dose-finding trial, Arthritis & Rheumatism, 2011, 63, 7
  29. 29
    Changhai Ding, Ran Li, Jianhua Xu, Flavia Cicuttini, Graeme Jones, Belimumab therapy for systemic lupus erythematosus and potential treatment of rheumatoid arthritis, Drug Development Research, 2011, 72, 7
  30. 30
    Qing-Tong Wang, Yu-Kun Ma, Bei Huang, Dan-Dan Liu, Wei Wei, Effect of rhTACI-Ig fusion protein on antigen-specific T cell responses from keyhole limpet haemocyanin challenged mice, Molecular Immunology, 2011, 49, 1-2, 380

    CrossRef

  31. 31
    G. A. Lied, A. Berstad, Functional and Clinical Aspects of the B-Cell-Activating Factor (BAFF): A Narrative Review, Scandinavian Journal of Immunology, 2011, 73, 1
  32. 32
    Dimitrios A. Pappas, Laura Geraldino-Pardilla, Joan M. Bathon, Immune modulation of rheumatoid arthritis, Best Practice & Research Clinical Rheumatology, 2011, 25, 6, 873

    CrossRef

  33. 33
    Ruth Dobson, Ute C. Meier, Gavin Giovannoni, More to come: Humoral immune responses in MS, Journal of Neuroimmunology, 2011, 240-241, 13

    CrossRef

  34. 34
    Maya H Buch, Paul Emery, New therapies in the management of rheumatoid arthritis, Current Opinion in Rheumatology, 2011, 23, 3, 245

    CrossRef

  35. 35
    Jean L Scholz, Eline T Luning Prak, Michael P Cancro, Targeting the BLyS family in autoimmunity: a tale of mouse and man, Clinical Investigation, 2011, 1, 7, 951

    CrossRef

  36. 36
    Y. Chang, Y. Wu, D. Wang, W. Wei, Q. Qin, G. Xie, L. Zhang, S. Yan, J. Chen, Q. Wang, H. Wu, F. Xiao, W. Sun, J. Jin, W. Wang, Therapeutic effects of TACI-Ig on rats with adjuvant-induced arthritis via attenuating inflammatory responses, Rheumatology, 2011, 50, 5, 862

    CrossRef

  37. 37
    D. Wang, Y. Chang, Y. Wu, L. Zhang, S. Yan, G. Xie, Q Qin, J. Jin, W. Wang, J. Fang, W. Wei, Therapeutic effects of TACI-Ig on rat with adjuvant arthritis, Clinical & Experimental Immunology, 2011, 163, 2
  38. 38
    Zhenhai Zhou, Xiaoyin Li, Juan Li, Chang Su, Lan Zhuang, Shaokai Luo, Ling Zhang, Direct B-cell Stimulation by Peripheral Blood Monocyte-derived Dendritic Cells in Idiopathic Thrombocytopenic Purpura Patients, Journal of Clinical Immunology, 2010, 30, 6, 814

    CrossRef

  39. 39
    G. Arslan Lied, K. Lillestøl, J. Valeur, A. Berstad, Intestinal B cell-activating factor: an indicator of non-IgE-mediated hypersensitivity reactions to food?, Alimentary Pharmacology & Therapeutics, 2010, 32, 1
  40. 40
    I. Nestorov, O. Papasouliotis, C. Pena Rossi, A. Munafo, Pharmacokinetics and immunoglobulin response of subcutaneous and intravenous atacicept in patients with systemic lupus erythematosus, Journal of Pharmaceutical Sciences, 2010, 99, 1
  41. 41
    M. Hegazy, H. Darwish, H. Darweesh, A. El-Shehaby, Y. Emad, Raised serum level of APRIL in patients with systemic lupus erythematosus: Correlations with disease activity indices, Clinical Immunology, 2010, 135, 1, 118

    CrossRef

  42. 42
    Martina Fabris, Salvatore De Vita, Nadia Blasone, Daniela Visentini, Elena Pezzarini, Elena Pontarini, Cinzia Fabro, Luca Quartuccio, Saulle Mazzolini, Francesco Curcio, Elio Tonutti, Serum levels of anti-CCP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab, Autoimmunity Highlights, 2010, 1, 2, 87

    CrossRef

  43. 43
    Stephen A. Mihalcik, Renee C. Tschumper, Diane F. Jelinek, Transcriptional and post-transcriptional mechanisms of BAFF-receptor dysregulation in human B lineage malignancies , Cell Cycle, 2010, 9, 24, 4884

    CrossRef

  44. 44
    Gerardo Ferrer, Kate Hodgson, Emili Montserrat, Carol Moreno, B cell activator factor and a proliferation-inducing ligand at the cross-road of chronic lymphocytic leukemia and autoimmunity, Leukemia & Lymphoma, 2009, 50, 7, 1075

    CrossRef

  45. 45
    Sandy D. Hong, Andreas Reiff, Hai-Tao Yang, Thi-Sau Migone, Christopher D. Ward, Katherine Marzan, Bracha Shaham, Wee Choo Phei, Judith Garza, Bram Bernstein, William Stohl, B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients, Arthritis & Rheumatism, 2009, 60, 11
  46. 46
    E. Marino, J. Villanueva, S. Walters, D. Liuwantara, F. Mackay, S. T. Grey, CD4+CD25+ T-Cells Control Autoimmunity in the Absence of B-Cells, Diabetes, 2009, 58, 7, 1568

    CrossRef

  47. 47
    Diana J. Auyeung-Kim, Madhav N. Devalaraja, Thi-Sau Migone, Wendy Cai, Gary J. Chellman, Developmental and peri-postnatal study in cynomolgus monkeys with belimumab, a monoclonal antibody directed against B-lymphocyte stimulator, Reproductive Toxicology, 2009, 28, 4, 443

    CrossRef

  48. 48
    Weijia Dong, Xiaoyan Li, Hui Liu, Ping Zhu, Infiltrations of plasma cells in synovium are highly associated with synovial fluid levels of APRIL in inflamed peripheral joints of rheumatoid arthritis, Rheumatology International, 2009, 29, 7, 801

    CrossRef

  49. 49
    Van Trung Chu, Philipp Enghard, Stefanie Schürer, Gudrun Steinhauser, Birgit Rudolph, Gabriela Riemekasten, Claudia Berek, Systemic activation of the immune system induces aberrant BAFF and APRIL expression in B cells in patients with systemic lupus erythematosus, Arthritis & Rheumatism, 2009, 60, 7
  50. 50
    Michael P. Cancro, David P. D’Cruz, Munther A. Khamashta, The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus, Journal of Clinical Investigation, 2009, 119, 5, 1066

    CrossRef

  51. 51
    E. Roosnek, M. Burjanadze, P.Y. Dietrich, T. Matthes, J. Passweg, B. Huard, Tumors that look for their springtime in APRIL, Critical Reviews in Oncology/Hematology, 2009, 72, 2, 91

    CrossRef

  52. 52
    Yanping Xiao, Seiichi Motomura, Eckhard R. Podack, APRIL (TNFSF13) regulates collagen-induced arthritis, IL-17 production and Th2 response, European Journal of Immunology, 2008, 38, 12
  53. 53
    P. P. Tak, R. M. Thurlings, C. Rossier, I. Nestorov, A. Dimic, V. Mircetic, M. Rischmueller, E. Nasonov, E. Shmidt, P. Emery, A. Munafo, Atacicept in patients with rheumatoid arthritis: Results of a multicenter, phase ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose study, Arthritis & Rheumatism, 2008, 58, 1
  54. 54
    F. Lavie, C. Miceli-Richard, M. Ittah, J. Sellam, J.-E. Gottenberg, X. Mariette, B-cell Activating Factor of the Tumour Necrosis Factor Family Expression in Blood Monocytes and T Cells from Patients with Primary Sjögren’s Syndrome, Scandinavian Journal of Immunology, 2008, 67, 2
  55. 55
    Changhai Ding, Belimumab, an anti-BLyS human monoclonal antibody for potential treatment of inflammatory autoimmune diseases, Expert Opinion on Biological Therapy, 2008, 8, 11, 1805

    CrossRef

  56. 56
    Lilian I. Reyes, Francisca León, Patricia González, María F. Rozas, Cristián Labarca, Alejandra Segovia, Oscar Neira, Rodrigo Naves, Dexamethasone inhibits BAFF expression in fibroblast-like synoviocytes from patients with rheumatoid arthritis, Cytokine, 2008, 42, 2, 170

    CrossRef

  57. 57
    Claire L. Gorman, Andrew P. Cope, Immune-mediated pathways in chronic inflammatory arthritis, Best Practice & Research Clinical Rheumatology, 2008, 22, 2, 221

    CrossRef

  58. 58
    M. Krumbholz, H. Faber, F. Steinmeyer, L.-A. Hoffmann, T. Kumpfel, H. Pellkofer, T. Derfuss, C. Ionescu, M. Starck, C. Hafner, R. Hohlfeld, E. Meinl, Interferon-  increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity, Brain, 2008, 131, 6, 1455

    CrossRef

  59. 59
    M. Carbonatto, P. Yu, M. Bertolino, E. Vigna, S. Steidler, L. Fava, C. Daghero, B. Roattino, M. Onidi, M. Ardizzone, S. Peano, J. Visich, D. Janszen, S. Dillon, R. Ponce, Nonclinical Safety, Pharmacokinetics, and Pharmacodynamics of Atacicept, Toxicological Sciences, 2008, 105, 1, 200

    CrossRef

  60. 60
    Ivan Nestorov, Alain Munafo, Orestis Papasouliotis, Jennifer Visich, Pharmacokinetics and Biological Activity of Atacicept in Patients With Rheumatoid Arthritis, The Journal of Clinical Pharmacology, 2008, 48, 4
  61. 61
    Patrizia Scapini, Flavia Bazzoni, Marco A. Cassatella, Regulation of B-cell-activating factor (BAFF)/B lymphocyte stimulator (BLyS) expression in human neutrophils, Immunology Letters, 2008, 116, 1, 1

    CrossRef

  62. 62
    Edward M. Vital, Paul Emery, The development of targeted therapies in rheumatoid arthritis, Journal of Autoimmunity, 2008, 31, 3, 219

    CrossRef

  63. 63
    M. Thangarajh, T. Masterman, J. Hillert, S. Moerk, R. Jonsson, A Proliferation-inducing Ligand (APRIL) is Expressed by Astrocytes and is Increased in Multiple Sclerosis, Scandinavian Journal of Immunology, 2007, 65, 1
  64. 64
    Irina Debnath, Kirstin M. Roundy, Janis J. Weis, John H. Weis, Analysis of the regulatory role of BAFF in controlling the expression of CD21 and CD23, Molecular Immunology, 2007, 44, 9, 2388

    CrossRef

  65. 65
    Jennifer Kwan-Morley, Daniel Albert, B-cell inhibitors as therapy for rheumatoid arthritis: An update, Current Rheumatology Reports, 2007, 9, 5, 401

    CrossRef

  66. 66
    Florian Emmerich, Gürkan Bal, Alaa Barakat, Julian Milz, Caroline Mühle, Lorena Martinez-Gamboa, Thomas Dörner, Abdulgabar Salama, High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura, British Journal of Haematology, 2007, 136, 2
  67. 67
    Sergio M Calixto, Chandra Mohan, Lupus genes at the interface of tolerance and autoimmunity, Expert Review of Clinical Immunology, 2007, 3, 4, 603

    CrossRef

  68. 68
    Maria Dall'Era, Eliza Chakravarty, Daniel Wallace, Mark Genovese, Michael Weisman, Arthur Kavanaugh, Kenneth Kalunian, Patricia Dhar, Emmanuelle Vincent, Claudia Pena-Rossi, David Wofsy, Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: Results of a multicenter, phase ib, double-blind, placebo-controlled, dose-escalating trial, Arthritis & Rheumatism, 2007, 56, 12
  69. 69
    Katsuya Nagatani, Kenji Itoh, Kyoichi Nakajima, Hirohumi Kuroki, Yozo Katsuragawa, Makoto Mochizuki, Shinichi Aotsuka, Akio Mimori, Rheumatoid arthritis fibroblast-like synoviocytes express BCMA and are stimulated by APRIL, Arthritis & Rheumatism, 2007, 56, 11
  70. 70
    Alain Munafo, Anthony Priestley, Ivan Nestorov, Jennifer Visich, Mark Rogge, Safety, pharmacokinetics and pharmacodynamics of atacicept in healthy volunteers, European Journal of Clinical Pharmacology, 2007, 63, 7, 647

    CrossRef

  71. 71
    M. Thangarajh, L. Kisiswa, R. Pirskanen, J. Hillert, The expression of BAFF-binding receptors is not altered in multiple sclerosis or myasthenia gravis, Scandinavian Journal of Immunology, 2007, 65, 5
  72. You have free access to this content72
    Natasha J. Hill, Monica Hultcrantz, Nora Sarvetnick, Malin Flodström-Tullberg, The target tissue in autoimmunity – an influential niche, European Journal of Immunology, 2007, 37, 3
  73. 73
    Lakhvir K. Assi, See Heng Wong, Andreas Ludwig, Karim Raza, Caroline Gordon, Michael Salmon, Janet M. Lord, Dagmar Scheel-Toellner, Tumor necrosis factor α activates release of B lymphocyte stimulator by neutrophils infiltrating the rheumatoid joint, Arthritis & Rheumatism, 2007, 56, 6
  74. 74
    Yulia Vugmeyster, Dhaya Seshasayee, Wesley Chang, Anahid Storn, Kathy Howell, Susan Sa, Tenea Nelson, Flavius Martin, Iqbal Grewal, Ellen Gilkerson, Ben Wu, Jeff Thompson, Barbara N. Ehrenfels, Song Ren, An Song, Thomas R. Gelzleichter, Dimitry M. Danilenko, A Soluble BAFF Antagonist, BR3-Fc, Decreases Peripheral Blood B Cells and Lymphoid Tissue Marginal Zone and Follicular B Cells in Cynomolgus Monkeys, The American Journal of Pathology, 2006, 168, 2, 476

    CrossRef

  75. 75
    Stacey R. Dillon, Jane A. Gross, Stephen M. Ansell, Anne J. Novak, An APRIL to remember: novel TNF ligands as therapeutic targets, Nature Reviews Drug Discovery, 2006, 5, 3, 235

    CrossRef

  76. 76
    William Stohl, R. John Looney, B cell depletion therapy in systemic rheumatic diseases: Different strokes for different folks?, Clinical Immunology, 2006, 121, 1, 1

    CrossRef

  77. 77
    Geraldine Cambridge, William Stohl, Maria J. Leandro, Thi-Sau Migone, David M. Hilbert, Jonathan C. W. Edwards, Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: Relationships with B cell depletion, circulating antibodies, and clinical relapse, Arthritis & Rheumatism, 2006, 54, 3
  78. 78
    E. Toubi, S. Gordon, A. Kessel, I. Rosner, M. Rozenbaum, Y. Shoenfeld, E. Zuckerman, Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: Association with autoimmunity, Journal of Autoimmunity, 2006, 27, 2, 134

    CrossRef

  79. 79
    R. Roque, R. Ponce, F. Burleson, M. Cabrit, H. Broly, M. Rogge, Influenza Virus Host Response of C57Bl/6 Mice Treated with TACI-Ig, Immunopharmacology and Immunotoxicology, 2006, 28, 1, 13

    CrossRef

  80. 80
    María Eugenia Miranda Carús, Papel patogénico de las interacciones entre linfocitos b y sinoviocitos tipo fibroblasto en la artritis reumatoide, Seminarios de la Fundación Española de Reumatología, 2006, 7, 2, 84

    CrossRef

  81. 81
    Monica Schaller, William Stohl, Vivian Benoit, Soon-Min Tan, Lene Johansen, Henrik J. Ditzel, Patients with inflammatory arthritic diseases harbor elevated serum and synovial fluid levels of free and immune-complexed glucose-6-phosphate isomerase (G6PI), Biochemical and Biophysical Research Communications, 2006, 349, 2, 838

    CrossRef

  82. 82
    Andrew P.R. Sutherland, Fabienne Mackay, Charles R. Mackay, Targeting BAFF: Immunomodulation for autoimmune diseases and lymphomas, Pharmacology & Therapeutics, 2006, 112, 3, 774

    CrossRef

  83. 83
    Gregg J. Silverman, Therapeutic B cell depletion and regeneration in rheumatoid arthritis: Emerging patterns and paradigms, Arthritis & Rheumatism, 2006, 54, 8
  84. 84
    Markus Krumbholz, Ulrich Specks, Manfred Wick, Susan L. Kalled, Dieter Jenne, Edgar Meinl, BAFF is elevated in serum of patients with Wegener's granulomatosis, Journal of Autoimmunity, 2005, 25, 4, 298

    CrossRef

  85. 85
    Mark C. Genovese, Biologic Therapies in Clinical Development for the Treatment of Rheumatoid Arthritis, JCR: Journal of Clinical Rheumatology, 2005, 11, Supplement, S45

    CrossRef

  86. 86
    Iain B McInnes, Foo Y Liew, Cytokine networks—towards new therapies for rheumatoid arthritis, Nature Clinical Practice Rheumatology, 2005, 1, 1, 31

    CrossRef

  87. 87
    Rémi J Creusot, C Garrison Fathman, Ulf Müller-Ladner, Ingo H Tarner, Targeted gene therapy of autoimmune diseases: advances and prospects, Expert Review of Clinical Immunology, 2005, 1, 3, 385

    CrossRef

  88. 88
    Lai Guan Ng, Charles R. Mackay, Fabienne Mackay, The BAFF/APRIL system: life beyond B lymphocytes, Molecular Immunology, 2005, 42, 7, 763

    CrossRef

  89. 89
    Susan L. Kalled, The role of BAFF in immune function and implications for autoimmunity, Immunological Reviews, 2005, 204, 1
  90. 90
    Robert H. Carter, B cells: New ways to inhibit their function in rheumatoid arthritis, Current Rheumatology Reports, 2004, 6, 5, 357

    CrossRef

  91. 91
    Kevin P Baker, BLyS—an essential survival factor for B cells: basic biology, links to pathology and therapeutic target, Autoimmunity Reviews, 2004, 3, 5, 368

    CrossRef

  92. 92
    Mathula Thangarajh, Andreia Gomes, Thomas Masterman, Jan Hillert, Peter Hjelmström, Expression of B-cell-activating factor of the TNF family (BAFF) and its receptors in multiple sclerosis, Journal of Neuroimmunology, 2004, 152, 1-2, 183

    CrossRef

  93. 93
    William Stohl, Targeting B lymphocyte stimulator in systemic lupus erythematosus and other autoimmune rheumatic disorders, Expert Opinion on Therapeutic Targets, 2004, 8, 3, 177

    CrossRef

  94. 94
    William Stohl, Samy Metyas, Soon-Min Tan, Gurtej S. Cheema, Bonifacia Oamar, Dong Xu, Viktor Roschke, Youmei Wu, Kevin P. Baker, David M. Hilbert, B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: Longitudinal observations, Arthritis & Rheumatism, 2003, 48, 12
  95. 95
    Kevin P. Baker, Bryan M. Edwards, Sarah H. Main, Gil H. Choi, Ruth E. Wager, Wendy G. Halpern, Patrick B. Lappin, Todd Riccobene, Donara Abramian, Les Sekut, Bonnie Sturm, Carol Poortman, Ralph R. Minter, Claire L. Dobson, Elizabeth Williams, Sara Carmen, Rodger Smith, Viktor Roschke, David M. Hilbert, Tristan J. Vaughan, Vivian R. Albert, Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator, Arthritis & Rheumatism, 2003, 48, 11